Related references
Note: Only part of the references are listed.Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Carl M. Gay et al.
CANCER CELL (2021)
YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed Phenotype
Taofeek K. Owonikoko et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Comparative study of clinicopathological characteristics and prognosis between combined and pure small cell lung cancer (SCLC) after surgical resection
Yiying Guo et al.
THORACIC CANCER (2020)
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization
Marina K. Baine et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Effect of histological subtype and treatment modalities on T1-2 N0-1 small cell lung cancer: A population-based study
Seok-whan Moon et al.
THORACIC CANCER (2019)
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Charles M. Rudin et al.
NATURE REVIEWS CANCER (2019)
A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy
Masahiro Shibata et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Loss of MiR-424-3p, Not miR-424-5p, Confers Chemoresistance Through Targeting YAP1 in Non-small Cell Lung Cancer
Meichun Zhang et al.
MOLECULAR CARCINOGENESIS (2017)
Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer
Karen McColl et al.
ONCOTARGET (2017)
Small-cell lung cancer: what we know, what we need to know and the path forward
Adi F. Gazdar et al.
NATURE REVIEWS CANCER (2017)
Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells
Haiying Cheng et al.
ONCOTARGET (2016)
Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistance
Jeong Eun Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Loss of YAP1 defines neuroendocrine differentiation of lung tumors
Takeshi Ito et al.
CANCER SCIENCE (2016)
YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer
Masafumi Horie et al.
CANCER SCIENCE (2016)
YAP promotes erlotinib resistance in human non-small cell lung cancer cells
Ping-Chih Hsu et al.
ONCOTARGET (2016)
Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms
Elisa Specht et al.
HISTOPATHOLOGY (2015)
Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer
Dean Yimlamai et al.
JOURNAL OF HEPATOLOGY (2015)
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Small Cell Lung Cancer: Where Do We Go From Here?
Lauren Averett Byers et al.
CANCER (2015)
The Hippo signaling pathway in stem cell biology and cancer
Jung-Soon Mo et al.
EMBO REPORTS (2014)
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes
Erica Lorenzetto et al.
ONCOTARGET (2014)
Combined SCLC Clinical and Pathologic Characteristics
Shahab Babakoohi et al.
CLINICAL LUNG CANCER (2013)
Comparison of Vinorelbine, Ifosfamide and Cisplatin (NIP) and Etoposide and Cisplatin (EP) for Treatment of Advanced Combined Small Cell Lung Cancer (cSCLC) Patients: A Retrospective Study
Jie Luo et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
Small-cell lung cancer
Jan P. van Meerbeeck et al.
LANCET (2011)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
Small cell lung carcinoma (SCLC) - A clinicopathologic study of 100 cases with surgical specimens
SA Nicholson et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
The new World Health Organization classification of lung tumours
E Brambilla et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Share Paper
